News
GlaxoSmithKline (GSK – Research Report) received a Hold rating and a $41.00 price target from Berenberg Bank analyst Kerry Holford today. Confident Investing Starts Here: Easily ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback